Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 7.3B | 7.0B | 7.1B | 7.2B |
Cost of revenue | 3.7B | 3.6B | 3.7B | 3.7B |
Gross profit | 3.6B | 3.4B | 3.4B | 3.4B |
Operating expense | ||||
Research & development | 32.7M | 32.7M | 33.5M | 31.8M |
Selling general and admin | 748.1M | 675.9M | 700.0M | 707.7M |
Other operating expenses | — | — | — | — |
Operating income | 2.0B | 1.9B | 1.9B | 1.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 57.6M | 51.6M | 244.2M | 58.5M |
Other income expense | 63.6M | 16.3M | 103.2M | -42.1M |
Pretax income | 2.0B | 1.9B | 1.9B | 1.8B |
Tax provision | 492.7M | 439.4M | 458.3M | 428.2M |
Net income | 1.6B | 1.5B | 1.5B | 1.4B |
Basic EPS | 3.8 | 3.5 | — | 3.2 |
Diluted EPS | 3.7 | 3.5 | — | 3.2 |
Basic average shares | 404.9M | 407.0M | — | 410.7M |
Diluted average shares | 407.2M | 409.5M | — | 413.5M |
EBITDA | 2.9B | 2.7B | 3.0B | 2.7B |
Net income from continuing op. | 1.5B | 1.5B | 1.6B | 1.3B |
Minority interests | -34.4M | -29.2M | -37.8M | -45.6M |
Preferred stock dividends | — | — | — | — |